Medical News

[ Calendar Blister Packaging Demonstrates Statistically Significant Improvement In Patient Medication Adherence ]

Calendar Blister Packaging Demonstrates Statistically Significant Improvement In Patient Medication Adherence

According to new data published in Clinical Therapeutics, the way a medication is packaged can have a significant impact on whether patients take it as prescribed. The study showed that Shellpak® calendar blister packaging from MeadWestvaco Corp. (NYSE: MWV) was associated with improvement in prescription adherence behavior in patients when compared with traditional pill vials. According to the researchers, a Shellpak-based adherence strategy could provide a substantial cumulative public health benefit when broadly implemented over a large population. Poor adherence to medication is a growing issue across the country. The New England Healthcare Institute estimates the current cost of drug-related morbidity, including poor adherence, to be as much as $290 billion annually in avoidable medical spending, 13% of total U.

Fuisz Announces Further Advances In Drug Compliance Verification For Opioids

Fuisz Pharma announced several advances in pharmaceutical compliance diagnostic systems, primarily directed at Opioids but also applicable to other drug classes. First, Fuisz placed its recent acquisition of the dominant, issued patent concerning the use of dyes and stains to demonstrate opioid misuse, within the larger context of Fuisz's compliance system. Fuisz calls this system Closed Loop Diagnostic System (CLDS). Fuisz Pharma's Managing Member, Joseph Matus Fuisz, explained: "Our primary concern is the demonstration of compliant, and alternatively non-compliant, use of an opioid. To this end, we include in the dosage form or in other ways a GRAS Trojan Agent. The Trojan Agent is selected to be readily identifiable in the compliant patient and in the abuser, whether on the nasal mucosa when snorted, in the urine when excreted, on the oral mucosa for orally dissolving dosage units or in other ways.

SAS Analytics Help High-Risk Patients Stay On Therapeutic Track

When patients stop taking prescribed drugs or reduce frequency or dosages, the effect can be devastating, causing health complications or even death. Express Scripts, one of the largest pharmacy benefit management companies in North America, trusts SAS Analytics to keep patients on their drug regimens to live healthier lives. Express Scripts handles millions of prescriptions annually. Using software from SAS, the leader in business analytics, the company predicts patients likely to abandon medication, offering intervention programmes to address potential issues before the patient becomes noncompliant. "When patients stop taking a prescribed drug against doctors' advice, it can significantly set back treatment, " said Jason Burke, managing director and chief strategist for the SAS Centre for Health Analytics and Insights (CHAI).

New Global Survey Reveals Over One In Three Patients Fail To Take Insulin As Prescribed

More than one in three diabetes patients skip doses or fail to take their insulin as prescribed, stating that they have done so on average three times in the last month, and 77 percent of physicians estimate that in reality this number could be as high as six doses, according to the Global Attitudes of Patients and Physicians in Insulin Therapy (GAPP™ ) survey, released by Novo Nordisk. The global survey, conducted in eight countries among almost 3, 000 respondents, also showed that 88 percent of physicians report that there are a significant proportion of patients still not reaching blood glucose targets, and four in 10 people with diabetes say they struggle to effectively control their blood sugar. These results are in line with previous research which has shown that globally less than half of people with diabetes reach an optimal level of health and quality of life.

Just What The Doctor Ordered, Take As Directed

If your usual cure for what ails you is to "take two pills and call in the morning" you might be in need of some better medical advice. Take as Directed is a new book from Dalhousie University pharmacy professor Neil MacKinnon and Dal Medical School alumni Rhonda Church. Aimed at helping Canadians from all walks of life navigate the health care system, Take as Directed is essential reading for anybody who is concerned about their health and well being. Written in plain language and offering common sense advice, the book attempts to demystify the health care system and offer Canadians a "behind the curtain" look at how physicians and pharmacists think and solve problems. Take as Directed is a welcome departure from the more typical avenue of academic publications especially prevalent in the health sciences field.

Fast: [10]

Medical News © Nanda
Designer Damodar